Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and... see more

TSXV:VPT - Post Discussion

VentriPoint Diagnostics Ltd > Privilege of attending the ESC Congress in London.Hugh 🌟
View:
Post by jopatclo on Sep 02, 2024 4:44pm

Privilege of attending the ESC Congress in London.Hugh 🌟

Over the long weekend, several of us had the privilege of attending the ESC Congress in London. This event was a fantastic platform for connecting with leading experts, potential partners, and key players in the finance community. Our time there was not only inspiring but also reinforced our confidence in the exciting path ahead for Ventripoint.

Our unique capability of delivering cMRI-level accuracy for right ventricle volumes and ejection fractions using echocardiography has clearly set us apart. The demand for similar accuracy across other heart chambers is evident, and our progress in enhancing VMS+ brings us closer to transitioning from clinical research to mainstream clinical practice. We're moving from general promotion to a more targeted approach, focusing on specific use cases and indications that will drive real impact.

Since Ventripoint's inception, our technology has been featured in approximately 60 publications, covering congenital heart defects, chemotherapy-induced cardiotoxicity, and pulmonary hypertension. The congress further solidified our belief that there are numerous additional opportunities to develop new propositions addressing critical clinical needs. These prospects offer considerable value and present multi-faceted market opportunities for our industry.

Our commercial team is actively exploring these opportunities to refine our revenue and business models, positioning us for a successful growth phase. Additionally, we've begun exploring ways to expand our sales team to strengthen our market presence as we approach the autumn and year-end.

In summary, the weekend was a highly productive and promising step forward. Stay tuned for more updates as we continue to build on this momentum.
Comment by jopatclo on Sep 02, 2024 7:13pm
Interesting comment Hugh Current selected sort order is Most relevant Most relevant   AlimonyCalculatorS.com 6,384 followers 4h     Exciting developments at Ventripoint ...more  
Comment by jopatclo on Sep 03, 2024 6:59am
Profile images for several LinkedIn members Dario Freitas and Richard Simpson like this   Hugh MacNaughtHugh MacNaught • Following • FollowingPresident and CEO at Ventripoint Diagnostics Ltd.President and CEO at Ventripoint Diagnostics Ltd.16h • 16 hours ago Over the long weekend, several of us had the privilege of ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities